ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne1998
Bioethics for clinicians: 14. Ethics and genetics in medicine.
Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- The Spectrum of Epidermolysis Bullosa in KwaZulu-Natal, South Africa.International journal of dermatology · 2025Observational
- Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.American journal of respiratory and critical care medicine · 2024Review
- The potential for misusing "genetic predisposition" in Canadian courts and tribunals.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011Article
- Attitudes of health care professionals toward pharmacogenetic testing.Molecular diagnosis & therapy · 2011Review
- Ethical issues in molecular medicine of relevance to surgeons.Canadian journal of surgery. Journal canadien de chirurgie · 2004Review
- The unique ethical challenges of conducting research in the rehabilitation medicine population.BMC medical ethics · 2003Article
- The very youngest science.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2002Article
- Conflict of interest in medical research in Estonia.Science and engineering ethics · 2002Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Information about a patient's inherited risk of disease has important ethical and legal implications in clinical practice. Because genetic information is by nature highly personal yet familial, issues of confidentiality arise. Counselling and informed consent before testing are important in view of the social and psychological risks that accompany testing, the complexity of information surrounding testing, and the fact that effective interventions are often not available. Follow-up counselling is also important to help patients integrate test results into their lives and the lives of their relatives. Genetic counselling should be provided by practitioners who have up-to-date knowledge of the genetics of and the tests available for specific diseases, are aware of the social and psychological risks associated with testing, and are able to provide appropriate clinical follow-up. Some physicians may elect to refer patients for genetic counselling and testing. However, it is inevitable that all physicians will be involved in long-term follow-up both by monitoring for disease and by supporting the integration of genetic information into patients' lives.
Indexed as
Identifiers
9614824PMC1229325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.